Exhaustive Study Notes on Ingestion and Digestion Disorders
GI Tract Overview, Cleft Lip, and Cleft Palate
The gastrointestinal (GI) tract is a continuous system extending from the mouth to the anus. Its primary function involves the ingestion and digestion of nutrients necessary for bodily function. Developmental abnormalities can occur in these structures, specifically presenting as Cleft Lip and/or Cleft Palate. These conditions are characterized by an abnormal opening in the lip, the palate, or both. Assessment for these conditions often begins prenatally through ultrasound diagnostics. Clinical manifestations are distinct: a Cleft Lip is visually apparent upon examination, while a Cleft Palate may be identified when formula is seen coming through the infant’s nose during feeding. Nursing interventions focus heavily on feeding assessments and the implementation of modified feeding techniques to ensure adequate nutrition. It is critical for nursing staff to assess the patient's fluid and calorie intake daily to monitor for growth and hydration.
Surgical treatment for Cleft Lip and Palate requires specific preoperative and postoperative protocols. Preoperatively, the patient must remain NPO (nothing by mouth), and the nursing staff must provide comprehensive education to the parents. Postoperatively, nursing care focuses on the maintenance of the suture line. To protect the surgical site, "No-No" restraints (elbow restraints) are used to prevent the infant from touching their face. Positioning is another key postoperative intervention to prevent injury to the site. Parental teaching for long-term management includes instruction on feeding techniques, the continued use of restraints as directed, and addressing the psychosocial implications of the condition for both the child and the family.
Esophageal Atresia and Tracheoesophageal Fistula
Esophageal Atresia (EA) and Tracheoesophageal Fistula (TEF) are congenital conditions resulting from the improper development of the esophagus and trachea. These two conditions most commonly occur together. Esophageal Atresia occurs when the esophagus and trachea fail to separate during development, leading to a blind pouch. Tracheoesophageal Fistula is defined as an abnormal connection between the trachea and the esophagus. Clinical assessment reveals excessive oral secretions and the "3 C’s" (often associated with coughing, choking, and cyanosis). Other manifestations include abdominal distention and vomiting. Diagnostics include prenatal ultrasound and radiograph imaging to visualize the anatomical abnormalities.
Treatment for EA and TEF requires surgical repair. This may involve the ligation of the fistula and an end-to-side anastomosis of the atresia. In some cases, a staged repair is necessary, which might include the creation of a gastrostomy or a cervical esophagostomy. Preoperative nursing care is intensive, requiring the patient to be NPO and the implementation of measures to prevent aspiration and maintain respiratory status. A nasogastric (NG) tube is typically placed in the proximal pouch to suction secretions. The head of the bed (HOB) must be kept elevated, and IV fluids and antibiotics (ABX) are administered. Postoperatively, the focus remains on respiratory status, necessitating frequent suctioning. Distal feedings may be initiated via tube, and Proton Pump Inhibitor (PPI) medications are administered to manage gastric acid. Families require education on aspiration prevention, monitoring for respiratory issues, and emotional support throughout the follow-up care process.
Pyloric Stenosis
Pyloric stenosis results from the hypertrophy of the circular muscle surrounding the pylorus, which leads to an obstruction of gastric emptying. This condition is characterized by specific clinical manifestations, most notably projectile, non-bilious vomiting. Infants with this condition often exhibit irritability and poor weight gain, which can lead to Failure to Thrive (FTT). Visible peristaltic waves may be observed moving across the abdomen. A hallmark diagnostic finding during palpation is an olive-shaped mass located in the Right Upper Quadrant (RUQ). Further diagnostics include ultrasound and Upper GI series imaging. Laboratory tests are performed to evaluate Liver Function Tests (LFTs) and electrolytes, as frequent vomiting can lead to severe imbalances.
Surgical intervention for pyloric stenosis is a pyloromyotomy, which involves an incision of the pyloric muscle to release the gastric obstruction. Preoperative nursing care includes keeping the patient NPO and providing IV fluids plus electrolyte replacement to stabilize the infant. Postoperatively, the nurse must monitor Intake and Output (), record daily weights, provide incision care, and manage the gradual reintroduction of feeding. Parent education is essential for a successful transition to home care.
Hiatal Hernia types and Manifestations
A hiatal hernia occurs when a portion of the stomach herniates through the diaphragm into the chest cavity. There are two primary types: Sliding and Rolling. A sliding hiatal hernia occurs when the stomach slides upward through the esophageal hiatus and moves freely. This type is commonly associated with esophageal reflux. A rolling hiatal hernia (paraesophageal) occurs when a portion of the stomach rolls upward next to the esophagus. This type is generally considered more serious, although it may not initially present with reflux.
Clinical manifestations vary by type. Patients with sliding hernias often experience heartburn, regurgitation, chest pain, dysphagia (difficulty swallowing), and belching. Patients with rolling hernias may report breathlessness after eating, a feeling of suffocation, and chest pain that mimics angina. In pediatric patients, manifestations include vomiting, coughing, wheezing, short periods of apnea, and failure to thrive. Management involves diagnostics such as a Barium Swallow or Esophagogastroduodenoscopy (EGD). Nonsurgical treatment includes medications like antacids, H2 blockers, and PPIs. Surgical options include a Nissen Fundoplication or a general hernia repair. Patient teaching is a vital component of long-term management.
Gastroesophageal Reflux Disease (GERD)
Gastroesophageal Reflux Disease (GERD) is the regurgitation of gastric contents back into the esophagus. Potential causes include hiatal hernia, obesity, delayed gastric emptying, smoking, and the consumption of certain foods or substances. Diagnostics for GERD include -hour pH monitoring, EGD, and esophageal manometry. In adults, symptoms include dyspepsia (heartburn), regurgitation, excessive salivation, dysphagia, belching, flatulence, and a chronic cough. Pediatric manifestations may include vomiting or spitting up, poor weight gain/FTT, and irritability. Some children experience "silent GERD," while older children may report epigastric pain.
Treatment for GERD involves diet modifications and positioning changes, such as lying on the left side or keeping the HOB elevated. Medication therapy includes antacids for symptom relief, H2 blockers and PPIs to decrease acid production, and prokinetics to increase gastric emptying. Endoscopic treatments include the Stretta procedure or endoluminal gastroplication. Severe cases may require a Laparoscopic Nissen Fundoplication (LNF). Patient and family education focuses on avoiding triggers like fatty, spicy, or acidic foods, as well as caffeine, soda, and chocolate. Lifestyle changes include smoking cessation, regular exercise, and the avoidance of NSAIDs. For pediatric patients, small frequent feeds and thickened formula are recommended. Medications should ideally be administered minutes before meals.
Gastritis
Gastritis occurs when the protective mucosal barrier of the stomach is compromised, resulting in mucosal injury and localized or patchy inflammation. This condition is categorized as either acute or chronic. Acute gastritis involves sudden inflammation of the mucosa and submucosa, typically lasting from hours to days. Chronic gastritis is characterized by long-term, patchy, diffuse inflammation that may be persistent or intermittent. The most common cause of chronic gastritis is Helicobacter pylori (H. pylori) infection. Acute clinical manifestations include sudden epigastric pain, nausea, vomiting, hematemesis (vomiting blood), gastric hemorrhage, and dyspepsia.
Chronic gastritis manifestations include dull epigastric pain or discomfort, decreased appetite, weight loss, nausea, vomiting, and Vitamin deficiency. Treatment for acute gastritis is largely supportive, involving NPO status and a gradual advance of the diet while avoiding triggers. Severe cases may require IV fluids and electrolyte replacement. Medications used for both types include PPIs, H2 blockers, antacids, and sucralfate. Chronic gastritis management focuses on eliminating causative factors and may require Vitamin supplementation. Nutrition should exclude spicy, caffeinated, or high-acid irritating foods, as well as alcohol and tobacco. Although rare, surgical options include vagotomy, gastrectomy, or pyloroplasty.
Peptic Ulcer Disease (PUD) and Zollinger-Ellison Syndrome
Peptic Ulcer Disease (PUD) involves mucosal lesions that impair the gastric mucosal defenses of the stomach or duodenum. The main causes are H. pylori infection and the use of NSAIDs. There are two major types: Gastric ulcers and Duodenal ulcers, the latter accounting for of cases. Gastric ulcer patients are often malnourished, have normal or low acid secretion, and experience pain to minutes after a meal that is worsened by food. Hematemesis is more common than melena. Duodenal ulcer patients are typically well-nourished, have acid hypersecretion, and experience pain at night that awakens them; this pain is often relieved by food. Melena (bloody stools) is more common than hematemesis. Treatment involves PPIs, H2 blockers, antacids, antiulcer agents, and specific treatment for H. pylori, alongside nutrition therapy and potentially surgery.
Zollinger-Ellison Syndrome is characterized by upper GI tract ulceration, increased gastric acid secretion, and the presence of a non-beta cell islet tumor of the pancreas known as a gastrinoma. This condition is caused by gastrin-secreting tumors and is an autosomal dominant disorder. Signs and symptoms are similar to PUD but also include diarrhea and steatorrhea (fatty stools). Drug therapy is similar to PUD but may also include chemotherapeutic agents and Sandostatin. Complete surgical resection, such as a Whipple Procedure, may be required.
Stomatitis types and Oral Health
Stomatitis, or oral mucositis, is the painful inflammation and ulceration of the protective lining of the mouth. Primary stomatitis includes aphthous stomatitis (noninfectious) and oral Herpes Simplex. Secondary stomatitis includes thrush (infectious). Common manifestations include painful mouth ulcers, cracked, dry, swollen, or red oral mucosa, and potential bleeding. Lesions are assessed for location, size, shape, color, odor, and drainage. Aphthous stomatitis (canker sores) are non-contagious, small, round/oval tender ulcers that turn from red to white, usually located on the buccal mucosa, lips, tongue, or palate. Treatment involves topical anesthetics and mouthwashes.
Oral Herpes Simplex (cold sores) is highly contagious and caused by HSV-1. It presents as clusters of painful fluid-filled vesicles and pruritus (itching) on the lips or the border of the lip. Antivirals like Acyclovir are used for treatment. Oral Thrush (Candidiasis) is a superficial fungal infection caused by Candida albicans. It manifests as white, creamy, plaque-like patches with an erythematous base, pain, and altered taste. Antifungals like Nystatin or Fluconazole are used. Nursing considerations for all stomatitis include oral care, pain management, and nutritional status monitoring. Patients should use a soft-bristle toothbrush, perform frequent mouth washing, stay hydrated, and follow a soft bland diet while avoiding alcohol-based mouthwash and spicy, acidic, or rough foods.
Celiac Disease and Enteral Nutrition
Celiac disease is a malabsorption disorder resulting from an inability to fully digest gluten, the protein found in wheat, barley, and rye. It is caused by a genetic immune hypersensitivity to gluten. Clinical manifestations include chronic diarrhea, steatorrhea, bloating, abdominal pain, weight loss, and vitamin deficiencies. Pediatric symptoms include vomiting and delayed growth. Diagnosis is confirmed via endoscopy and biopsy. The primary treatment is diet therapy, which requires the strict avoidance of wheat, barley, and rye, accompanied by nutritional supplementation. The acronym C-E-L-I-A-C is used to guide management.
Enteral nutrition may be necessary for patients with significant GI or ingestion issues. This can be achieved through a Gastrostomy, where a stoma is created through the abdominal wall into the stomach for the insertion of a short feeding tube. Alternatively, a Nasogastric (NG) tube may be used, which is inserted nasally and advanced into the GI tract to administer total enteral nutrition.